BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11585759)

  • 21. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania.
    El-Fadili A; Richard D; Kündig C; Ouellette M
    Biochem Pharmacol; 2003 Sep; 66(6):999-1008. PubMed ID: 12963486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
    Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
    Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on the relationship between the resistance to MTX and the transport protein superfamily of ATP-binding cassette that induces multiple drug resistance].
    Zhang CY; Feng YX; Li P; Fu SB
    Yi Chuan; 2006 Oct; 28(10):1201-5. PubMed ID: 17035174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.
    Zelcer N; Saeki T; Bot I; Kuil A; Borst P
    Biochem J; 2003 Jan; 369(Pt 1):23-30. PubMed ID: 12220224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3/Abcc3) facilitates intestinal absorption of folates in mouse.
    Kitamura Y; Kusuhara H; Sugiyama Y
    Pharm Res; 2010 Apr; 27(4):665-72. PubMed ID: 20148291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function.
    Létourneau IJ; Slot AJ; Deeley RG; Cole SP
    Drug Metab Dispos; 2007 Aug; 35(8):1372-9. PubMed ID: 17494643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholate.
    Stark M; Rothem L; Jansen G; Scheffer GL; Goldman ID; Assaraf YG
    Mol Pharmacol; 2003 Aug; 64(2):220-7. PubMed ID: 12869626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
    Grant CE; Gao M; DeGorter MK; Cole SP; Deeley RG
    Drug Metab Dispos; 2008 Dec; 36(12):2571-81. PubMed ID: 18775981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of the human folate receptor mediates transport-defective methotrexate resistance in KB cells.
    Saikawa Y; Knight CB; Saikawa T; Page ST; Chabner BA; Elwood PC
    J Biol Chem; 1993 Mar; 268(7):5293-301. PubMed ID: 7680349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retentiveness of methotrexate polyglutamates in cultured L1210 cells. Evidence against a role for mediated plasma membrane transport outward.
    Schlemmer SR; Sirotnak FM
    Biochem Pharmacol; 1993 Mar; 45(6):1261-6. PubMed ID: 7682074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 cells. Basic properties and specificity for polyglutamate chain length.
    Barrueco JR; Sirotnak FM
    J Biol Chem; 1991 Jun; 266(18):11732-7. PubMed ID: 1711038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models.
    Breedveld P; Pluim D; Cipriani G; Dahlhaus F; van Eijndhoven MA; de Wolf CJ; Kuil A; Beijnen JH; Scheffer GL; Jansen G; Borst P; Schellens JH
    Mol Pharmacol; 2007 Jan; 71(1):240-9. PubMed ID: 17032904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents.
    Zeng H; Bain LJ; Belinsky MG; Kruh GD
    Cancer Res; 1999 Dec; 59(23):5964-7. PubMed ID: 10606242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells.
    Paumi CM; Wright M; Townsend AJ; Morrow CS
    Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and growth inhibitory effects of the erythro and threo isomers of gamma-fluoromethotrexate, a methotrexate analogue defective in polyglutamylation.
    McGuire JJ; Graber M; Licato N; Vincenz C; Coward JK; Nimec Z; Galivan J
    Cancer Res; 1989 Aug; 49(16):4517-25. PubMed ID: 2472880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
    McGuire JJ; Haile WH; Yeh CC
    Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leucovorin rescue of human cancer and bone marrow cells following edatrexate or methotrexate.
    Jolivet J; Jansen G; Peters GJ; Pinard MF; Schornagel JH
    Biochem Pharmacol; 1994 Feb; 47(4):659-65. PubMed ID: 7510479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.
    Göker E; Kheradpour A; Waltham M; Banerjee D; Tong WP; Elisseyeff Y; Bertino JR
    Leukemia; 1995 Feb; 9(2):274-6. PubMed ID: 7532768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.